Yes biotech development
Rob Carlson 21 - PhD, managing director at Bioeconomy Capital & affiliate professor in the Paul G Allen School of Computer Science & Engineering at the University of Washington "Beyond Biological Defense: Maintaining the U.S. Biotechnology Advantage," War on the Rocks, https://warontherocks.com/2021/09/beyond//AL
The global growth of the sector is likely to accelerate demand for the pro ducts of biotech. New tools, decreasing costs and an expanding skill base imply that more people in more places will have access to more powerful technology (4,30,31). Governments around the globe are grappling with the desire to benefit from biotech-driven economic development, while simultaneously facing questions about who should have access to which technology and under what circumstances. The US government has taken an official position that physical and economic security, in addition to economic and employment growth, are best served by encouraging and embracing open access and innovation in biotech in all contexts, "from cutting-edge academic institutes, to industrial research centers, to private laboratories in basements and garages" (32). This position sets the stage for a necessary refocusing of biosecurity discussions and practices. Relying on biotech to produce economic growth requires support both for research and job creation and for safe and secure use in equal measure. These goals are hampered at present by the lack of data and reporting on biotech as an industry. Addressing these deficiencies in measurement is a necessary first step in accurately quantifying the role of biotech in the economy. The voluntary ignorance resulting from the absence of such data confounds an understanding of national security that surely must include the economic role of biotech in the context of both biological production and natural resources. Consequently, it is important to better discern the impact of underlying technological development on physical and economic security and on the economy as a whole. Biosecurity has typically been interpreted as the physical security of individuals, institutions and the food supply in the context of threats such as toxins and pathogens. These will, of course, continue to be important concerns. Yet governments can no longer limit their concern to the proverbial white powder produced in a state-sponsored lab, a 'cave' in Afghanistan or a garage in Seattle (33). Safeguarding the large and rapidly growing bioeconomy requires embracing a more substantial challenge; it is essential to have a refined and ongoing understanding of what must be secured and from where threats might arise. Economic demand is driving technological proliferation, and the revenue estimates described here must necessarily inform the evolving definition of biosecurity. Alongside the preexisting bioeconomy, we are building a system composed of inherently 'dual-use' engineering technologies that will constitute critical infrastructure for the future economy. Assuming that the revenue and growth estimates above are borne out with improved measurement and analysis, biosecurity is now clearly synonymous with economic security. The focus of biosecurity policy must shift from protecting specific targets from specific threats to securing the bioeconomy as a system that increasingly drives economic growth and employment and, ultimately, enables humans to thrive on a global scale.